Crescita Therapeutics Inc. (CRRTF)
USD 0.45
(0.0%)
USD 0.45
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.07 Million | -1.02 Million | -1.59 Million | 5.6 Million | 5.3 Million | -1.47 Million |
| Net Income | -1.98 Million | 862 Thousand | -1.1 Million | 37 Thousand | 1.85 Million | 2.39 Million |
| Depreciation & Amortization | 1.5 Million | 1.47 Million | 1.37 Million | 1.49 Million | 1.72 Million | 1.14 Million |
| Deferred income taxes | 456 Thousand | -458 Thousand | 96 Thousand | 483 Thousand | 1.32 Million | -1.77 Million |
| Stock-based compensation | 82 Thousand | 221 Thousand | 272 Thousand | 155 Thousand | 287 Thousand | 342 Thousand |
| Change in working capital | 1.6 Million | -3.71 Million | -1.46 Million | 1.58 Million | 1.72 Million | -2.95 Million |
| Other non-cash items | 412 Thousand | 599 Thousand | -773 Thousand | 1.86 Million | -1.61 Million | -635 Thousand |
| Investing Cash Flow | -133 Thousand | -290 Thousand | -846 Thousand | -59 Thousand | -215 Thousand | -144 Thousand |
| Investments in PPE | -133 Thousand | -229 Thousand | -346 Thousand | -59 Thousand | -215 Thousand | -144 Thousand |
| Acquisitions | - | -61 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -61 Thousand | -500 Thousand | - | - | - |
| Financing Cash Flow | -782 Thousand | -1.84 Million | -500 Thousand | -476 Thousand | -4.39 Million | 3.18 Million |
| Debt repayment | -408 Thousand | -1.37 Million | -349 Thousand | -358 Thousand | -3.88 Million | -300 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -393 Thousand | -429 Thousand | -101 Thousand | -68 Thousand | -257 Thousand | - |
| Common Stock Issuance | 19 Thousand | 6000.00 | - | - | - | 3.52 Million |
| Other Financing Activities | 19 Thousand | -44 Thousand | -50 Thousand | -50 Thousand | -250 Thousand | -334 Thousand |
| Accounts receivables | 3.53 Million | -2.57 Million | -1.04 Million | 1.24 Million | 2.8 Million | -3.88 Million |
| Accounts payables | -1.28 Million | 232 Thousand | 993 Thousand | 332 Thousand | 163 Thousand | 510 Thousand |
| Inventory | -917 Thousand | -1.78 Million | -1.37 Million | -41 Thousand | -1.33 Million | 318 Thousand |
| Other working capital | 271 Thousand | 405 Thousand | -42 Thousand | 45 Thousand | 92 Thousand | 611 Thousand |
| Cash at beginning of period | 8.23 Million | 11.33 Million | 14.28 Million | 9.26 Million | 8.58 Million | 6.99 Million |
| Cash at end of period | 9.38 Million | 8.23 Million | 11.33 Million | 14.28 Million | 9.26 Million | 8.58 Million |
| Capital Expenditure | -133 Thousand | -229 Thousand | -346 Thousand | -59 Thousand | -215 Thousand | -144 Thousand |
| Effect of forex changes on cash | -14 Thousand | 63 Thousand | -7000.00 | -60 Thousand | -18 Thousand | 28 Thousand |
| Net cash flow / Change in cash | 1.14 Million | -3.09 Million | -2.95 Million | 5.01 Million | 679 Thousand | 1.59 Million |
| Free Cash Flow | 1.94 Million | -1.24 Million | -1.94 Million | 5.54 Million | 5.09 Million | -1.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -926 Thousand | -626 Thousand | -150 Thousand | -1.98 Million | -1.28 Million | -281 Thousand |
| Depreciation & Amortization | 304 Thousand | 385 Thousand | 379 Thousand | 1.5 Million | 377 Thousand | 375 Thousand |
| Deferred income taxes | - | - | 197 Thousand | 456 Thousand | 99 Thousand | 93 Thousand |
| Stock-based compensation | 54 Thousand | 21 Thousand | -21 Thousand | 82 Thousand | 16 Thousand | 65 Thousand |
| Change in working capital | 1.08 Million | 696 Thousand | -879 Thousand | 1.6 Million | 966 Thousand | -321 Thousand |
| Other non-cash items | -575 Thousand | -50 Thousand | 213 Thousand | 412 Thousand | -51 Thousand | 150 Thousand |
| Investing Cash Flow | -912 Thousand | - | -105 Thousand | -133 Thousand | -28 Thousand | - |
| Investments in PPE | -912 Thousand | - | -105 Thousand | -133 Thousand | -28 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -158 Thousand | -236 Thousand | -258 Thousand | -782 Thousand | -324 Thousand | -101 Thousand |
| Debt repayment | -110 Thousand | -108 Thousand | -105 Thousand | -408 Thousand | -103 Thousand | -101 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -48 Thousand | -78 Thousand | -153 Thousand | -393 Thousand | -240 Thousand | - |
| Common Stock Issuance | - | - | - | 19 Thousand | 19 Thousand | - |
| Other Financing Activities | - | -50 Thousand | - | 19 Thousand | 19 Thousand | - |
| Accounts receivables | 1.27 Million | -601 Thousand | -274 Thousand | 3.53 Million | 1.36 Million | 532 Thousand |
| Accounts payables | -75 Thousand | 348 Thousand | -408 Thousand | -1.28 Million | 424 Thousand | -1 Million |
| Inventory | 66 Thousand | 996 Thousand | -394 Thousand | -917 Thousand | -671 Thousand | -1000.00 |
| Other working capital | -184 Thousand | -47 Thousand | 197 Thousand | 271 Thousand | -148 Thousand | 150.99 Thousand |
| Cash at beginning of period | 9.53 Million | 9.38 Million | 10.02 Million | 8.23 Million | 10.22 Million | 10.27 Million |
| Cash at end of period | 9.01 Million | 9.53 Million | 9.38 Million | 9.38 Million | 10.02 Million | 10.22 Million |
| Capital Expenditure | -912 Thousand | - | -105 Thousand | -133 Thousand | -28 Thousand | - |
| Effect of forex changes on cash | 4000.00 | 4000.00 | -12 Thousand | -14 Thousand | 22 Thousand | -29 Thousand |
| Net cash flow / Change in cash | -519 Thousand | 146 Thousand | -636 Thousand | 1.14 Million | -205 Thousand | -49 Thousand |
| Free Cash Flow | -365 Thousand | 378 Thousand | -366 Thousand | 1.94 Million | 97 Thousand | 81 Thousand |
3269
4441
603995
3687
093050
FMFG